Neurocognitive Sweden AB

Active
559364-9261Limited company (AB)Registered 2022STOCKHOLM

Key figures

1 855 000 kr+3,5%
Revenue 2025
+3,5%
Average annual growth 2024–2025
0500 k1 m1,5 m2 m20242025

Key figures

2025

Summary: Neurocognitive Sweden AB

What kind of company is it?

Neurocognitive Sweden AB (org. no. 559364-9261) is a limited company (AB). The company was registered in 2022 and has existed for 4 years. Registered seat: Stockholm. Industry according to Statistics Sweden: specialist medical practice activities, not at hospitals (SNI 86222).

How is the company doing financially?

Net sales in financial year 2025 were 1 855 000 kr, up 3,5 % on the previous year (1 793 000 kr). Net profit for 2025 was 552 065 kr (29,8 % of net sales). Employees in financial year 2025: 1. Net sales per employee were 1 855 000 kr. At the end of financial year 2025, total assets were 1 456 406 kr and equity 1 306 745 kr (equity ratio 89,7 %). The annual report for 2025 proposes a dividend of 343 500 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 343 500 kr.

Summary of annual reports2024–2025
20242025
Sales revenue1 793 0001 855 000
Profit for the reporting year579 228552 065
Retained earnings of previous periods——
Total assets834 1541 456 406
Total liabilities79 474149 661
Total equity754 6801 306 745
Employees—1
Proposed dividend—343 500

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.